This compansy' shares have crashed 77 percent YTD. Consolidation may offer a new entry opportunity for this restructuring drug company. It is highly unlikely to go bankrupt. The drug company reaffirmed its revenue guidance as part of its 2nd quarter earnings release, and guided for significant debt reductions on the back of asset sales and free cash flow. Further, its new Chief Executive Officer put $8 billion of non core asset sales on the table in order to pay down the drug company's debt.
Drug company Valeant Pharmaceuticals International, Inc. (NYSE:VRX) was the most exciting story in the stock market of 2015/6 if you ask me. Unfortunately, shareholders of Valeant Pharmaceuticals that bought into the acquisition model a year ago are now sitting on devastating losses. I can only say congrats to all those investors that jumped off the sinking ship in time last year, and those investors that actually shorted the drug company.
Source: Seeking Alpha
Related Articles:
- 7 Undervalued, Big-Name Stocks To Consider For Your Dividend Portfolio
- 7 High-Yield Energy Stocks Growing Their Dividends
- 5 Dividend Stocks In Need Of A Market Correction
- 10 Dividend Stocks Building A Growing Cash Stream
- How To Build A Sustainable High Yield Portfolio
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
Showing resilience during a tough week was a group of stocks that has not been heard from much in the past two years. A group that has been ...
-
Anxiety over the European debt crisis and distrust in the markets drove volatility in global stock markets to dizzying heights in 2011. The ...
-
In bull markets, dividends become more or less irrelevant. When the Dow Jones Industrial Average traded above 14,000 in 2007, very few stoc...
-
Whether you are looking to supplement your income or looking to build wealth over very long periods of time, dividend stocks that can reliab...
-
There have been a lot of business cycles over the past five decades, ups and downs through which it takes astute leadership to survive and t...
-
I own roughly 30 stocks in my personal portfolio, but there are some I bought because I think they're currently undervalued -- not neces...
-
This BDC remains a "Strong Buy". It has a diversified investment portfolio with considerable NII-upside. Shares sell for a premium...
-
A safe yield and solid growth prospects are a must for any investor in real estate investment trusts -- and this company not only has these ...
-
The S&P 500 might be on one of its strongest bull runs ever, but there are several solid dividend stocks out there that haven't quit...
-
Finding an attractive dividend stock in the technology sector isn't difficult, despite the notion that tech companies are miserly when i...
0 comments
Post a Comment
Post a Comment